Roche receives CE Mark for Alzheimer’s rule out test
Roche Holding AG received CE mark for its Elecsys pTau181 test to help rule out Alzheimer’s disease. The…
Roche’s Gen 6 Troponin T test accurately diagnosing heart attacks
Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is…
Roche secures CE mark for kidney disease algorithm
Roche Holdings AG received CE-mark for the Kidney Klinrisk algorithm, an AI-based tool developed in collaboration with Klinrisk…